top of page
The Dual-Agonist Era: How GIP/GLP-1 Receptor Agonists are Reshaping Our T2D Treatment Algorithm
Explore how the advent of dual-agonists like tirzepatide is challenging the standard of care and where it fits in the modern hierarchy of T2D treatment options.
Dr Aravind Reddy
14. Sept.4 Min. Lesezeit
bottom of page